Home - Products - Others - Other Targets - herbacetin-3,8-diglucopyranoside

herbacetin-3,8-diglucopyranoside

CAS No. 99224-12-1

herbacetin-3,8-diglucopyranoside( Linocinamarin )

Catalog No. M29462 CAS No. 99224-12-1

herbacetin-3,8-diglucopyranoside is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 182 In Stock
5MG 227 In Stock
10MG 353 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    herbacetin-3,8-diglucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    herbacetin-3,8-diglucopyranoside is a natural product.
  • Description
    herbacetin-3,8-diglucopyranoside is a natural product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Linocinamarin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    99224-12-1
  • Formula Weight
    1251.02
  • Molecular Formula
    C54H58O34
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc(c(OC(c(cc1)ccc1O)=C1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)c(c(O)c2)C1=O)c2OOC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc(c(OC(c(cc1)ccc1O)=C1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)c(c(O)c2)C1=O)c2O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DCZ0415

    DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.

  • Oleuroside

    Oleuroside can protect against mitochondrial dysfunction in models of early Alzheimer's disease and brain ageing.

  • Etebenecid

    Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.